Repligen Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2025: -1.27%

Repligen Corporation Return on Equity (ROE) is -1.27% for the Trailing 12 Months (TTM) ending March 31, 2025, a -204.19% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • Repligen Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2024 was 1.22%, a -91.86% change year over year.
  • Repligen Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2023 was 15.04%, a 38.29% change year over year.
  • Repligen Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2022 was 10.87%, a -18.47% change year over year.
  • Repligen Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2021 was 13.34%, a 331.66% change year over year.
Key Data
Date Return on Equity (ROE) Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share